TCTR20230710001
Completed
Not Applicable
Development of clinical prediction rules for predicting patients' ability to return to pre-fracture activities of daily living status at one year following fragility hip fracture
/A0 sites421 target enrollmentJuly 10, 2023
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fragility hip fracture
- Sponsor
- /A
- Enrollment
- 421
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Fragility hip fracture patients, who aged more than 50 years and had a minimum follow\-up time of 1 year or until death.
Exclusion Criteria
- •Multiple fractures or fractures caused by cancer confirmed by pathological study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Development of a Clinical Prediction Rule for Text Messaging to increase physical activity in patients with heart diseaseJPRN-UMIN000043236Sonoda third hospital90
Completed
Not Applicable
Clinical prediction score development for predicting 28-day mortality of elderly sepsis patients in emergency departmentdevelop clinical prediction score for the predicted 28-day mortality of suspicious elderly sepsis patients in the emergency departmentclinical prediction score28-day mortalitysuspicious elderly sepsis patientsemergency departmentTCTR20220507005Faculty of medicine Ramathibodi Hospital599
Not yet recruiting
Not Applicable
Development of a prediction models for clinical outcomes of patients with peritoneal dialysis based on home-based monitoring : Using deep learning methodsDiseases of The genitoruinary systemKCT0005608Yonsei University Health System, Severance Hospital100
Completed
Phase 2
Development of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic ManipulationShoulder PainNCT00835302University of Colorado, Denver80
Recruiting
Not Applicable
Establishment of the method for predicting clinical effect of tocilizumab based on its serum concentration in rheumatoid arthritis patientsrheumatoid arthritisJPRN-UMIN000041153Department of Hospital pharmacy Hamamatsu University School of Medicine50